CClinicalTrials.gg
RecruitingNCT07130812Updated May 18, 2026

Blood Flow Restriction Training as a Targeted Intervention for Rowers With Back Pain.

An interventional study of blood flow restriction and Heavy load resistance training in Low Back Pain, sponsored by Loma Linda University. Recruiting at 1 site in United States. Open to participants aged 13 Years to 20 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-18.

Sponsored by Loma Linda University · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year later.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
13 Years to 20 Years
Sex
All
01

Study summary

The purpose of this graduate student research study is to compare the effects of low-load blood flow restriction training (LL-BFR) and heavy-load training (HLT) in high-volume rowers with mild low back pain or recurrent low back pain (LBP), aiming to determine whether LL-BFR offers a safer yet equally effective alternative to HLT for enhancing performance and reducing risk of re-injury.

Read the detailed description

Rowers will complete a web-based survey administered via administered via Google Forms for up to 15 minutes. Questions will address demographics, attendance adherence to rowing practice/races, a blood flow restriction pre-screening questionnaire, and the Orebro Musculoskeletal Pain Questionnaire (OMPQ) for LBP. Rowers will participate in a 2000-meter indoor rowing ergometer time trial to assess, technical fatigue, muscular fatigue, and performance. Muscular fatigue will be assessed through the use of Electromyography (EMG) collected via Noraxon Ultium electrodes and sensors on the hamstrings and quadriceps. Performance on the 2000-meter time trial will be determined by improvement of time to completion. Performance will be further assessed through a 1-repetition maximum (1RM) test for squat and deadlifts. Strength and endurance ratios will also be collected assessing hamstrings: quadriceps using an Asani tension dynamometer and abdominal endurance. Rowers will then be split into two groups (exercise and sham) through blocked randomization: light-load blood flow restriction training (LL-BFR) and heavy load training (HLT). Each LL-BFR session will include the following strength exercises at 20-30% of each participant's 1 RM: (1) Squats (Goblet/Back squat), (2) Deadlifts (Conventional/Romanian), (3) Side planks, (4) Plank, and (5) Bird-Dogs. The exercises will follow a 4-set structure: Set 1 with 30 repetitions, followed by three sets of 15 repetitions, with 30-second rests between each set. Participants will report their rating of perceived exertion (RPE) on a 1-10 scale, aiming to maintain an RPE of 7-8; load and occlusion pressure can be adjusted accordingly. The HLT will participate in the same exercises but under a different dosage of 6 sets and 5 reps at 60-80% 1 RM.

02

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • blood flow restriction
03

In context

Low Back Pain

2,818 studies on the registry are indexed under Low Back Pain; 482 are open to participants now.

This study's planned enrollment of 120 is above the median of 60 across 2,268 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Loma Linda University is the lead sponsor of 297 studies on the registry; 48 are open to participants now.

Of its 28 completed or terminated interventional studies of FDA-regulated products, 23 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 13-20 years old
  • Currently active rower (training ≥3 days/week or 12 hours/week)
  • Mild LBP with a low reactivity (\<3/10) or recurring LBP within the past 18 months that has affected attendance to team practices/races.
  • Able to complete a 2,000-meter rowing erg test

Exclusion criteria

Exclusion Criteria:

  • Have severe or acute back pain that limits basic movement or requires medical treatment
  • History of spinal surgery or structural spine conditions (scoliosis requiring bracing/surgery)
  • Have a contraindication to BFR training, identified via BFR safety screening form:
  • Peripheral vascular disease (PVD)
  • History of vascular surgery in arms or legs
  • Skin grafts on arms or legs
  • Arteriovenous fistula in limbs
  • Cognitive or physical impairment that limits participation
  • Hypertension or high blood pressure (uncontrolled or undiagnosed)
  • Bleeding disorders (e.g., hemophilia)
  • Blood clotting disorders (e.g., lupus, factor-V Leiden)
  • Past history of DVT or pulmonary embolism (PE)
  • Surgery in the past 12 weeks
  • Recent limb immobilization (e.g., cast, boot) in the last 4 weeks
  • History of stroke or transient ischemic attack (TIA)
  • History of cancer
  • Diagnosed heart disease
  • History of rhabdomyolysis
  • Diagnosed diabetes
  • Sickle cell disease
  • History of compartment syndrome
  • History of nerve damage or injury
  • Any prior complications or adverse reactions to BFR training
  • Any other medical conditions that should be cleared by a physician before starting BFR
  • Pregnancy(Self-reported)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Blood Flow Restriction Group

    Using blood flow restriction, participants partake in aerobic (rowing) and anaerobic (squats/deadlifts) exercises.

    Other: blood flow restriction

  • Active comparator
    Non Blood Flow Restriction Group

    Participants partake in aerobic and anaerobic exercises without blood flow restrictions. The participants will use heavier loads in the anaerobic exercises.

    Other: Heavy load resistance training

Interventions

  • Otherblood flow restriction

    The SAGA blood flow restriction tourniquet system will be used for each training sessions for the rowers within the light load restriction group. The 4 inch-wide tourniquet will be applied to both upper thighs during the strength and endurance exercises. Tourniquet setting will be determined as the pressure needed to achieve 40-80% arterial occlusion to the extremity (as measured by the SAGA BFR unit). The SAGA units provides a consistent amount of pressure to the extremity throughout the ROM of the exercise. The settings will be determined at baseline and then recalibrated weekly.

  • OtherHeavy load resistance training

    For the resistance prescription, rowers will do strengthening exercises at 70-80% 1 RM. Exercises will be performed in series following 6 sets by 5 reps, with 120 seconds of rest between sets for each exercise.

06

What researchers measure

Primary outcomes

  1. Hamstring and quadricep muscular fatigue assessment via Noraxon Electromyography

    Time frame: change between baseline and 10 weeks

07

Study locations

1 of 1 sites recruiting
  • Loma Linda University
    Loma Linda, California 92350, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — We are not decided yet.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07130812
Lead sponsor
Loma Linda University
Responsible party
Sponsor
First posted
Aug 19, 2025
Start date
Sep 29, 2025
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
May 18, 2026

Study contacts

Everett Lohman, DSc
Contact
elohman@llu.edu
(909) 558-1000 ext. 83171
Everett Lohman, Dsc
principal investigator · Loma Linda University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion